Endogenous expression of proteases in colon cancer cells facilitate influenza A viruses mediated oncolysis

Cancer Biology and Therapy

Volumn 10, Issue 6, 2010, Pages 592-599

  Sturlan, Sanda ^a,b   Stremitzer, Stefan ^a   Bauman, Suzann ^a   Sachet, Monika ^a   Wolschek, Markus ^b   Ruthsatz, Tanja ^b   Egorov, Andrej ^b   Bergmann, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Avir Green Hills Biotechnology AG   (Austria)

Author keywords

Colon cancer; Influenza A virus; Oncolysis; Protease; Trypsin; Virotherapy

Indexed keywords

INFLUENZA VIRUS NONSTRUCTURAL PROTEIN 1 80; ONCOLYTIC VIRUS; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROTEIN EXPRESSION; VIRUS ISOLATION; VIRUS REPLICATION;

ANIMALS; CACO-2 CELLS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COLONIC NEOPLASMS; FEMALE; HCT116 CELLS; HOST-PATHOGEN INTERACTIONS; HT29 CELLS; HUMANS; INFLUENZA A VIRUS; MICE; MICE, SCID; MUTATION; NEOPLASMS, EXPERIMENTAL; ONCOLYTIC VIRUSES; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDE HYDROLASES; TRANSPLANTATION, HETEROLOGOUS; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77957117274     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.6.12565     Document Type: Article

References (23)

1. Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, Katinger D, et al. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 1998; 72:6437-41.
2. Bergmann M, Romirer I, Sachet M, Fleischhacker R, Garcia-Sastre A, Palese P, et al. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res 2001; 61:8188-93.
3. Yamamoto H, Iku S, Adachi Y, Imsumran A, Taniguchi H, Nosho K, et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003; 199:176-84. (Pubitemid 36176023)
4. Zhirnov O, Klenk HD. Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells. Virology 2003; 313:198-212.
5. Muster T, Rajtarova J, Sachet M, Unger H, Fleischhacker R, Romirer I, et al. Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants. Int J Cancer 2004; 110:15-21.
6. Allen C, Vongpunsawad S, Nakamura T, James CD, Schroeder M, Cattaneo R, et al. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res 2006; 66:11840-50.
7. Kangasniemi L, Kiviluoto T, Kanerva A, Raki M, Ranki T, Sarkioja M, et al. Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer. Clin Cancer Res 2006; 12:3137-44.
8. Allen C, McDonald C, Giannini C, Peng KW, Rosales G, Russell SJ, Galanis E. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas. J Gene Med 2004; 6:1216-27.
9. Kinoh H, Inoue M, Komaru A, Ueda Y, Hasegawa M, Yonemitsu Y. Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies. Gene Ther 2009; 16:392-403.
10. Williams SJ, Gotley DC, Antalis TM. Human trypsinogen in colorectal cancer. Int J Cancer 2001; 93:67-73.
11. Bernard-Perrone F, Carrere J, Renaud W, Moriscot C, Thoreux K, Bernard P, et al. Pancreatic trypsinogen I expression during cell growth and differentiation of two human colon carcinoma cells. Am J Physiol 1998; 274:1077-86.
12. Kato Y, Nagashima Y, Koshikawa N, Miyagi Y, Yasumitsu H, Miyazaki K. Production of trypsins by human gastric cancer cells correlates with their malignant phenotype. Eur J Cancer 1998; 34:1117-23. (Pubitemid 28308356)
13. Hirahara F, Miyagi Y, Miyagi E, Yasumitsu H, Koshikawa N, Nagashima Y, et al. Trypsinogen expression in human ovarian carcinomas. Int J Cancer 1995; 63:176-81.
14. Koivunen E, Saksela O, Itkonen O, Osman S, Huhtala ML, Stenman UH. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer 1991; 47:592-6.
15. Yamamoto H, Iku S, Itoh F, Tang X, Hosokawa M, Imai K. Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer 2001; 91:1324-31.
16. Ollier L, Caramella A, Giordanengo V, Lefebvre JC. High permissivity of human HepG2 hepatoma cells for influenza viruses. J Clin Microbiol 2004; 42:5861-5. (Pubitemid 39664380)
17. Scheiblauer H, Reinacher M, Tashiro M, Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis 1992; 166:783-91.
18. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997; 72:1-22.
19. Schmitt M, Magdolen V. Using kallikrein-related peptidases (KLK) as novel cancer biomarkers. Thromb Haemost 2009; 101:222-4.
20. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. The role of interferon in influenza virus tissue tropism. J Virol 1998; 72:8550-8.
21. Hirasawa K, Nishikawa SG, Norman KL, Alain T, Kossakowska A, Lee PW. Oncolytic reovirus against ovarian and colon cancer. Cancer Res 2002; 62:1696-701. (Pubitemid 34408491)
22. Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J Virol 1996; 70:4188-92.
23. Zhirnov OP, Ikizler MR, Wright PF. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol 2002; 76:8682-9.